Compare DCOM & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DCOM | INSP |
|---|---|---|
| Founded | 1864 | 2007 |
| Country | United States | United States |
| Employees | 902 | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | N/A | 2018 |
| Metric | DCOM | INSP |
|---|---|---|
| Price | $36.52 | $41.34 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 16 |
| Target Price | $37.80 | ★ $94.00 |
| AVG Volume (30 Days) | 252.4K | ★ 1.3M |
| Earning Date | 04-23-2026 | 05-04-2026 |
| Dividend Yield | ★ 2.81% | N/A |
| EPS Growth | N/A | ★ 179.43 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $82,050,000.00 |
| Revenue This Year | $21.40 | $8.02 |
| Revenue Next Year | $12.65 | $8.11 |
| P/E Ratio | $14.81 | ★ N/A |
| Revenue Growth | N/A | ★ 62.18 |
| 52 Week Low | $25.16 | $39.61 |
| 52 Week High | $38.00 | $147.03 |
| Indicator | DCOM | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 50.19 | 36.35 |
| Support Level | $34.86 | $39.61 |
| Resistance Level | $36.73 | $44.98 |
| Average True Range (ATR) | 0.93 | 2.40 |
| MACD | -0.01 | 0.22 |
| Stochastic Oscillator | 47.20 | 35.57 |
Dime Community Bancshares Inc operates as a holding company. The company gathers deposits from customers within its market area and via the internet and invests them in multifamily residential, commercial real estate, commercial and industrial (C&I) loans, and one-to-four family residential real estate loans, and mortgage-backed securities, obligations of the U.S. government and government- sponsored enterprises (GSEs), and corporate debt and equity securities. The company has one reportable segment which is Community Banking.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.